Navigation Links
RAPS Honors Dexter, Shorer and Novales-Li for Outstanding Contributions to Healthcare Product Regulatory Profession
Date:9/14/2009

PHILADELPHIA, Sept. 14 /PRNewswire-USNewswire/ -- The Regulatory Affairs Professionals Society (RAPS) today honored the recipients of its prestigious awards for outstanding contributions to the healthcare product regulatory profession. RAPS' Leonard Stauffer Award for mentoring and furthering regulatory professional education was given to independent consultant Nanci Dexter. RAPS' Global Leadership Award for contributions to worldwide development of the profession was awarded to Shy Shorer of the National Institutes of Health and RAPS' Special Recognition Award for unique contributions was bestowed upon Philipp Novales-Li of Novartis. Awardees were honored during the opening session of the 2009 RAPS Annual Conference & Exhibition in Philadelphia.

(Logo: http://www.newscom.com/cgi-bin/prnh/20070314/DCW091LOGO)

Each year, RAPS' awards pay tribute to outstanding regulatory professionals who have made significant contributions to the profession and to RAPS. Award winners are recognized by their colleagues for their hard work, dedication, leadership and accomplishments. The award recipients are nominated by their peers and selected by the RAPS Awards Committee.

The Leonard Stauffer Award recognizes exceptional contributions to mentoring and furthering regulatory professional education development including special achievements related to Regulatory Affairs Certification (RAC). Stuaffer Award recipient Nanci Dexter, MS, RAC, is an independent global regulatory affairs and quality assurance consultant. Her work experience over the past 22 years includes IVDs, biologics, pharmaceuticals and medical devices in both startup and large company environments. Dexter received the Leonard Stauffer Award in recognition of her efforts in establishing the RAC Study Group of the Rocky Mountain Regulatory Affairs Society (RMRAS).

The Global Leadership Award recognizes professionals who exemplify leadership and contributions toward development of the regulatory profession and toward increasing awareness of RAPS in societies and economies worldwide. Award recipient Shy Shorer, MD, MBA, RAC, is the director of the Office of Clinical Research Affairs, Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health. He received the Global Leadership Award in recognition of his role in advocating for RAPS and the Regulatory Affairs Certification (RAC) credential internationally.

The Special Recognition Award recognizes unique contributions and achievements of individuals and organizations that advance the quality of health and the regulatory profession. Award recipient Philipp Novales-Li, DMedSc, PhD, DPhil (Oxon), RAC, is a regulatory affairs scientist, specializing in medical devices and in vitro diagnostics. His work experience includes serving as associate director of regulatory affairs at Novartis, and previously, as manager of regulatory affairs at Abbott Diabetes Care and as director of regulatory and scientific affairs at BioGenex. An avid writer and researcher, Novales-Li received the Special Recognition Award for his efforts to share regulatory knowledge and provide mentorship to his peers, and for conducting research on regulatory topics and sharing the results with other regulatory and business professionals via publications and lectures.

Members of the working media who wish to cover all or part of the 2009 RAPS Annual Conference & Exhibition should send an email to RAPS Communications Manager Zachary Brousseau at zbrousseau@raps.org or may register on site by going to the press office in room 104A of the Pennsylvania Convention Center. Media must bring valid press credentials or a letter from an assigning editor on company letterhead.

Conference sponsors include: Anson Group, Boston Scientific, BSI Healthcare, Crimson/Transperfect, Elsevier Business Intelligence, GE Healthcare, Kendle, Prolifiq Software, Stericycle and Tarius.

About RAPS

The Regulatory Affairs Professionals Society (RAPS) is an international membership organization of regulatory professionals in the rapidly growing medical device, pharmaceutical and biotechnology sectors. Regulatory professionals play vital roles in making better healthcare products possible. They work throughout the healthcare product lifecycle, ensuring these products are safe and effective, while driving organizational strategy and sound decision-making. RAPS supports these individuals and the regulatory profession by providing education and training, Regulatory Affairs Certification (RAC), professional standards, research, knowledge-sharing, publications, networking, career development opportunities and other valuable resources; and is committed to helping its members continually develop the knowledge and skills they need to excel. RAPS is headquartered near Washington, DC, with offices in Brussels and Tokyo. RAPS.org


'/>"/>
SOURCE Regulatory Affairs Professionals Society (RAPS)
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. VA Honors Veterans Who Are Artists, Performers
2. 7 Days Across America Campaign Honors Teens Making a Difference in Their Communities
3. Council for American Medical Innovation Honors Health Champion Senator Edward M. Kennedy
4. Chicago Mayor Honors Astellas Excellence in Learning, Development
5. Journal of Midwifery & Womens Health honors outstanding authors
6. Grifols Honors Texas Plasma Donors During Plasma Protein Therapies Month
7. Thirteen Courage Center Youth Athletes Take Top Honors in National Sports Competition
8. National Foundation for Infectious Diseases honors VCU physician with Maxwell Finland Award for 2010
9. AMERIGROUP Foundation Honors Warehouse of Hope Founder Craig Parson as a Healthy Hero
10. THA Honors 12 Legislators for Contributions to Health Care
11. School of Health Management Honors 162 Graduating Students
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... ... ... June 19, 2016 is World Sickle Cell Observance Day. In an effort ... holistic treatments, Serenity Recovery Center of Marne, Michigan, has issued a pain ... Disease (SCD) is a disorder of the red blood cells, which can cause episodes ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... Sessions in Dallas that it will receive two significant new grants to support ... as PHA marked its 25th anniversary by recognizing patients, medical professionals and scientists ...
(Date:6/24/2016)... ... June 24, 2016 , ... Dr. ... accelerated orthodontic treatment. Dr. Cheng has extensive experience with all areas of orthodontics, ... and accelerated osteogenic orthodontics. , Micro-osteoperforation is a revolutionary adjunct to orthodontic ...
(Date:6/24/2016)... , ... June 24, 2016 , ... Topical BioMedics, Inc, makers of Topricin and MyPainAway ... call for a minimum wage raise to $12 an hour by 2020 and then adjusting ... restore the lost value of the minimum wage, assure the wage floor does not erode ...
(Date:6/24/2016)... Georgia (PRWEB) , ... June 24, 2016 , ... ... awards today at the Clinical Decision Making in Emergency Medicine conference in Ponte ... have authored journal articles published in Emergency Medicine Practice and Pediatric ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... June 26, 2016 One of Australia,s ... the formation of a new biotechnology company, Noxopharm Limited [ABN 50 ... an IPO and to list on the ASX. Noxopharm ... ready to enter a Phase 1 clinical study later this year. ... address one of the biggest problems facing cancer patients - the ...
(Date:6/26/2016)... , June 27, 2016 Jazz Pharmaceuticals ... waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of ... acquisition of Celator Pharmaceuticals, Inc. ("Celator"; Nasdaq: ... p.m. (Eastern Daylight Time). As previously announced ... into a definitive merger agreement under which Jazz Pharmaceuticals ...
(Date:6/26/2016)... , June 27, 2016  VMS Rehab Systems, ... Board will take whatever measures required to build a ... stock which is currently listed on the OTC Markets-pink ... Company Chairman and CEO, "We are seeing an anomaly ... to understand, not only by the Company, but shareholders ...
Breaking Medicine Technology: